Richard Roxburgh: Young kiwi to be first to trial new muscular dystrophy drug
The Mike Hosking Breakfast · Newstalk ZB
June 30, 20244m 5s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease.
The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy.
Neurologist and trial lead Richard Roxburgh says the method is promising.
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
Topics
muscular dystrophy